Last updated on July 2019

A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus

Brief description of study

The purpose of this study is to assess the effect of canagliflozin relative to placebo on glycated hemoglobin (HbA1c) after 26 weeks of treatment, and to assess the overall safety and tolerability of canagliflozin.

Clinical Study Identifier: NCT03170518

Find a site near you

Start Over

Arkansas Childrens Hospital

Little Rock, AR United States
  Connect »

Advanced Clinical Research

Anaheim, CA United States
  Connect »

TOPAZ Clinical Research

Apopka, FL United States
  Connect »

Johns Hopkins All Children's Hospital

Saint Petersburg, FL United States
  Connect »

Asclepes Research

Spring Hill, FL United States
  Connect »

Appalachian Clinical Research

Adairsville, GA United States
  Connect »

Alas Viable Research

Henderson, NV United States
  Connect »

University of New Mexico

Albuquerque, NM United States
  Connect »

Carolinas Research Center, LLC

Charlotte, NC United States
  Connect »

PMG Research of Wilmington, LLC

Wilmington, NC United States
  Connect »

Medical Research South, LLC

Charleston, SC United States
  Connect »

Driscoll Children's Hospital

Corpus Christi, TX United States
  Connect »

Baylor College of Medicine

Houston, TX United States
  Connect »

Sante Clinical Research

Kerrville, TX United States
  Connect »

Sun Research Institute

San Antonio, TX United States
  Connect »

MultiCare Health System

Tacoma, WA United States
  Connect »

Hospital Pulau Pinang

George Town, Malaysia
  Connect »

Hospital Putrajaya

Putrajaya, Malaysia
  Connect »

Davao Doctors Hospital

Davao City, Philippines
  Connect »

Docbebet Diabetes Clinic

San Fernando City, Philippines
  Connect »

LifeDoc Research, PLLC

Memphis, TN United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.